cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy

Using state-of-the-art strategies, our results establish that cDC1s have a proatherogenic role in atherosclerosis by boosting CD4<sup>+</sup> and CD8<sup>+</sup> T-cell immunity and propose that cDC1s can be targeted with an immunosuppressive drug to decrease atherosclerosis progression.

Authors

Institutions

Publication Details

Journal
Circulation Research
Published
2025-05-30
DOI
https://doi.org/10.1161/circresaha.124.325792
Citations
3
Primary Topic
Atherosclerosis and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
2.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy

Elena Hernández‐García, Almudena R. Ramiro, Vanessa Núñez, Ana Rodríguez-Ronchel et al.
3 citations
Circulation Research
Atherosclerosis and Cardiovascular Diseases
2.39
article

cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy

Elena Hernández‐García, Almudena R. Ramiro, Vanessa Núñez, Ana Rodríguez-Ronchel, Laura Fernández‐Méndez, Susana Carregal‐Romero, Stefanie K. Wculek, Ana Dopazo, Kenneth M. Murphy, David Sancho, Sandrine Henri, Bernard Malissen, Alberto Benguría, Suin Jo, Sarai Martínez-Cano, Iñaki Robles‐Vera, Elena Moya-Ruiz, Jesús Ruı́z-Cabello, Carlos Relaño‐Rupérez, Tiantian Liu, Miguel Á. Galán, Manuel Rodrigo-Tapias, Marcos Femenía-Muiña, Pau Figuera-Belmonte
article en
3 citations

Abstract

Using state-of-the-art strategies, our results establish that cDC1s have a proatherogenic role in atherosclerosis by boosting CD4<sup>+</sup> and CD8<sup>+</sup> T-cell immunity and propose that cDC1s can be targeted with an immunosuppressive drug to decrease atherosclerosis progression.

Circulation ResearchVol. 137(3)
Université de Tours (FR), Ikerbasque (ES), Universidad Complutense de Madrid (ES), Centre National de la Recherche Scientifique (FR), Inserm (FR), University of the Basque Country (ES), Universidad de Alcalá (ES), Washington University in St. Louis (US), CIC biomaGUNE (ES), Centro de Investigación en Red en Enfermedades Cardiovasculares (ES), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES), Inmunotek (Spain) (ES), Centro de Investigación Biomédica en Red (ES), Institute for Research in Biomedicine (ES), Spanish National Centre for Cardiovascular Research (ES), Centre d’Immunologie de Marseille-Luminy (FR), Universidad Autónoma de Madrid (ES)
Good health and well-being
Openalex Percentile: Top 11%
Atherosclerosis and Cardiovascular Diseases
2.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.